spacer
spacer

PDBsum entry 6c0s

Go to PDB code: 
protein ligands links
Hydrolase/hydrolase inhibitor PDB id
6c0s

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
238 a.a.
Ligands
EEJ
SO4
EDO ×12
Waters ×141
PDB id:
6c0s
Name: Hydrolase/hydrolase inhibitor
Title: Factor xia in complex with the inhibitor methyl (4-{6-[(1s)-2-[(3r)-1- acetylpiperidin-3-yl]-1-({(2e)-3-[5-chloro-2- (1h-tetrazol-1-yl) phenyl]prop-2-enoyl}amino)ethyl]-3-chloropyridazin-4-yl}phenyl) carbamate
Structure: Coagulation factor xi. Chain: a. Fragment: light chain (unp residues 388-625). Synonym: fxi, plasma thromboplastin antecedent, pta. Engineered: yes. Mutation: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: f11. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
Resolution:
2.35Å     R-factor:   0.197     R-free:   0.226
Authors: S.Sheriff
Key ref: Z.Hu et al. (2018). Pyridazine and pyridazinone derivatives as potent and selective factor XIa inhibitors. Bioorg Med Chem Lett, 28, 987-992. PubMed id: 29501396 DOI: 10.1016/j.bmcl.2018.02.049
Date:
02-Jan-18     Release date:   07-Mar-18    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P03951  (FA11_HUMAN) -  Coagulation factor XI from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
625 a.a.
238 a.a.*
Key:    PfamA domain  Secondary structure
* PDB and UniProt seqs differ at 2 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class: E.C.3.4.21.27  - coagulation factor XIa.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Selective cleavage of Arg-|-Ala and Arg-|-Val bonds in factor IX to form factor IXa.

 

 
DOI no: 10.1016/j.bmcl.2018.02.049 Bioorg Med Chem Lett 28:987-992 (2018)
PubMed id: 29501396  
 
 
Pyridazine and pyridazinone derivatives as potent and selective factor XIa inhibitors.
Z.Hu, C.Wang, W.Han, K.A.Rossi, J.M.Bozarth, Y.Wu, S.Sheriff, J.E.Myers, J.M.Luettgen, D.A.Seiffert, R.R.Wexler, M.L.Quan.
 
  ABSTRACT  
 
Pyridazine and pyridazinone derivatives were designed and synthesized as coagulation factor XIa inhibitors. Potent and selective inhibitors with single digit nanomolar affinity for factor XIa were discovered. Selected inhibitors demonstrated moderate oral bioavailability.
 

 

spacer

spacer